MAULDIN, SC / ACCESSWIRE / October 24, 2023 / Xcelerate, Inc. (OTCQB:XCRT) today announced the publication of its two utility patent applications, US 18/187,352 and US 18/189,441, by the United States Patent and Trademark Office (USPTO).
MAULDIN, SC / September 14, 2023 / Xcelerate, Inc. (OTCQB:XCRT) today announced that ESN Group, Inc., a subsidiary of Xcelerate, has been designated as an approved vendor to the Army & Air Force Exchange Service (“AAFES”).
AFTER ACQUIRING ESN GROUP, XCELERATE SIGNS MARKETING AGREEMENT ProductSector to Provide Brand Development Assistance MAULDIN, SC / ACCESSWIRE / August 8, 2023 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has signed a strategic marketing agreement
MAULDIN, SC / ACCESSWIRE / July 25, 2023 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has completed its acquisition of a majority interest in both ESN Group, Inc. and California Skin Research, Inc., (collectively the
Jun 08, 2023 (ACCESSWIRE via COMTEX) — MAULDIN, SC / ACCESSWIRE / June 8, 2023 /Xcelerate, Inc. (OTCQB:XCRT), is pleased to provide an update on the company’s recent progress and developments. In an interview with Tiger
Mauldin, SC., May 25, 2023 —Xcelerate, Inc. (OTCQB: “XCRT”) today announced that the Shell Risk Symbol that has been attached to its OTC Markets page since moving to the OTCQB Market has been removed. For more information:
Mauldin, SC., May 23, 2023 —Xcelerate, Inc. (OTCQB: “XCRT”) today announced that Mike O’Shea, CEO, would participate in a live interview on Wednesday, 24 May, 2023 at 1:00PM EST . “I am pleased to have the
MAULDIN, SC / ACCESSWIRE / April 20, 2023 / Xcelerate, Inc. (OTCQB:XCRT) announced today it filed two utility patent applications under application numbers 18/187,352 and 18/189,441. Additionally, corresponding PCT applications were filed under PCT/US2023/015755 and PCT/US2023/016194.
MAUDLIN, SC / ACCESSWIRE / April 12, 2023 / Xcelerate, Inc. (OTCQB:XCRT) announced today that it had completed its’ due diligence and has entered into a binding agreement to acquire a controlling interest in ESN Group,
Agreement is next step to provide AI based healthcare services in Africa Mauldin, SC., March 29, 2023 —Xcelerate, Inc. (OTCQB: “XCRT”) today, announced that Afya Sasa Africa LLC, a subsidiary of Xcelerate signed an Agreement to
Agreement is intended to be the initial step to provide AI based health care services in Africa. MAULDIN, SC / ACCESSWIRE / March 14, 2023 / Xcelerate, Inc. (OTCQB:XCRT) today announced that Afya Sasa Africa LLC,
Company Raised Close to $400K Mauldin, SC., February 3, 2023 –Xcelerate, Inc. (OTCQBs: “XCRT”) today announced that it has closed its Reg A+ offering, raising almost $400,000 in additional equity financing. The Offering that was qualified on
MAULDIN, SC / ACCESSWIRE / February 1, 2023 / Xcelerate, Inc. (OTCQB:XCRT) today announced that Fabian Urquijo has accepted an invitation to join its Xcelerate Brands Advisory Board. Fabian Urquijo is originally from Argentina. He received
Xcelerate, Inc. Executes Letter of Intent to Acquire a Controlling Interest in ESN, Inc. MAULDIN, SC / ACCESSWIRE / January 17, 2023 / Xcelerate, Inc. (OTCQB:XCRT) announced today that it had entered into a letter of
MAULDIN, SC / ACCESSWIRE / January 3, 2023 / Xcelerate, Inc.‘s (OTCQB:”XCRT”) Mike O’Shea, CEO, today released this letter and shareholder update. I would like to first thank our shareholders for their continued support throughout 2022
Xcelerate, Inc. to Develop Consumer Healthcare Products Based on Its Current Patent Portfolio. MAULDIN, SC / ACCESSWIRE / August 30, 2022 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it had begun an initiative to identify marketing/manufacturing
MAULDIN, SC / ACCESSWIRE / August 23, 2022 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has received patent protection in nine additional countries Korean Claim – In April 2022 our Korean Application, #10-2019-7006227, was allowed
Mauldin, SC., August 2, 2022 –Xcelerate, Inc. (OTC Markets: “XCRT”) today announced that its C.E.O., Michael O’Shea will be interviewed by Tiger Free Stock today announced that its C.E.O., Michael O’Shea will be interviewed by Tiger
MAULDIN, SC / ACCESSWIRE / August 1, 2022 / Xcelerate, Inc. (OTCQB:XCRT), today announces that the OTC Market Group has approved the Company’s application for uplisting to the OTCQB® Venture Market (the “OTCQB”). The Company will
MAULDIN, SC / ACCESSWIRE / June 22, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it has initiated its plan to upgrade the trading of its common stock from the OTC Pink Market to the
MAULDIN, SC / ACCESSWIRE / June 7, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that Cathy Scangarella has accepted an invitation to join its Advisory Board effective immediately. Cathy Scangarella is the Chief Business Development
Wilken, O’Shea Talk Acquisition of HS Pharmaceuticals and What It Means for The Future Of XCRT CEO Mike O’Shea of Xcelerate, Inc., a development stage startup focused on the development of cutting-edge medtech applications, met
